Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
about
Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically)Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) through medical treatment (iatrogenically)Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles.Epidemiological characteristics of human prion diseasesCreutzfeldt-Jakob disease: a case report and differential diagnosesIsolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathyIn vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoformsHuman prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects.Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease.The expanding universe of prion diseases.Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002.Genomic and post-genomic analyses of human prion diseasesHuman prion diseases in the United States.Application of "omics" to prion biomarker discovery.Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United KingdomA novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach.Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.A test for Creutzfeldt-Jakob disease using nasal brushings.Unusual deterioration in a patient with multiple sclerosis on natalizumab therapyNo reactivation of JCV and CMV infections in the temporal cortex and cerebellum of sporadic Creutzfeldt-Jakob disease patients.Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob diseaseEvidence for synergistic effects of PRNP and ATP7B mutations in severe neuropsychiatric deterioration.Human prion disease and relative risk associated with chronic wasting disease.Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998-2012.Neurological deaths of American adults (55-74) and the over 75's by sex compared with 20 Western countries 1989-2010: Cause for concern.Iatrogenic Creutzfeldt-Jakob disease, final assessment.Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology.Human prion diseases: progress in clinical trials.Cerebrospinal fluid markers in Creutzfeldt-Jakob disease.Therapeutic approaches for prion disorders.Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.Creutzfeldt-Jakob Disease: Analysis of Four Cases.Ethics in prion disease.Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt-Jakob disease.Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral NeuropathyDoxycycline in early CJD: a double-blinded randomised phase II and observational study.Creutzfeldt-Jakob disease cluster in the health area of Meixoeiro Hospital.Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease.
P2860
Q24235721-12E598CF-90B2-417E-9A7D-E2C0847FCEC7Q24242392-D05CEE2E-7F41-455D-A691-8B4378C3386CQ25257725-D19D9089-323B-4B36-A1B1-3045CF04BD65Q26744136-C636F9AC-0206-4DE4-9796-759DF9ACD640Q27026439-9CE3AE6B-C597-4BEF-AAD1-9E686C3A47DDQ28469063-C0303620-4BA5-4210-8871-5EEA6DC5ABBEQ28475550-C3F03452-852B-4D2F-BA75-AD5A7503AF42Q30467870-A44DF6D5-A28E-4136-94F4-325F9EAA61A9Q31095751-B77FE9EB-6999-40CB-B6EB-5892E8833882Q33239695-91CACC99-274C-4CD6-AB8C-4942385AD2BBQ33263263-4656F8B6-232B-49DB-BD51-2B895429DD57Q33347355-50B1615C-8180-40E0-9A7D-3A09D271E2D0Q33521903-E0C56897-E963-4450-8E6F-7E1301B7EF5EQ33708360-A1AC5D6C-25BA-415F-A9BE-095214651906Q33724591-07621C84-A8EB-48C7-AB58-A1D123E725D2Q33727322-6FBFD50D-9C9B-43CE-9821-B1405A250C06Q33728522-A6F03D7C-2936-462D-8BDF-04D8438F70F5Q34059789-5D6BBD4A-D66E-4C34-BF36-F0FD271D885BQ34070015-0AC53F94-96A3-4AE1-9F6E-BB19785A36E8Q34293962-9DEB6DB0-095D-4225-B665-31B390B12EB6Q34368638-FFC3D37C-5B72-48E4-BBCA-B6A55B24EB33Q34987502-9EB6EEFA-8D5C-4AF7-BC26-9B9AAA2675C1Q35088040-21DAB152-96AA-40A4-A6D7-C5FEDB6B03D7Q35098831-2D70F94A-22EA-4378-859E-C428B99467A5Q35792137-6AA651F3-10DB-4064-A06D-93BA273E2B15Q35859408-51A9C597-36DF-409F-9684-17C3CD82B94EQ35905910-1147A3FD-031A-430F-B3C4-446A4A0BF2A3Q35979990-FB552FF5-C79A-49F0-B27F-B8D4691E9C8BQ36475223-5A716A47-79A6-41E0-BF49-0FF240612F0AQ36732854-79F44048-DDE1-4B5F-A1B1-9B812FFEFCEBQ36865663-29BB4AE7-F983-4FBC-9805-88246B4C02ABQ36901944-D17E6A37-C014-45B4-901F-47319CC2FF97Q37053839-57C6C76F-DD95-431A-B17F-A588F7803BF1Q37212447-A642EBA9-B8F6-4CE1-B51B-049B4D85D4D9Q37282279-998B61BB-E068-40E3-B187-9E3B0B476191Q37385010-B2C252EC-CABF-47E1-9B49-F155CA245A30Q37491711-E061D9D5-0A6D-4F44-8894-5678805A79E2Q37617090-5EE036EE-7B54-4A1F-88F5-AE7307E5B504Q38010461-2EC58D8C-981B-4EEF-B6DB-68C1952A8AC9Q38025005-C85E7B45-76AE-4486-B11B-170D0C7946D6
P2860
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Mortality from Creutzfeldt-Jak ...... Europe, Australia, and Canada.
@en
Mortality from Creutzfeldt-Jak ...... Europe, Australia, and Canada.
@nl
type
label
Mortality from Creutzfeldt-Jak ...... Europe, Australia, and Canada.
@en
Mortality from Creutzfeldt-Jak ...... Europe, Australia, and Canada.
@nl
prefLabel
Mortality from Creutzfeldt-Jak ...... Europe, Australia, and Canada.
@en
Mortality from Creutzfeldt-Jak ...... Europe, Australia, and Canada.
@nl
P2093
P50
P1433
P1476
Mortality from Creutzfeldt-Jak ...... Europe, Australia, and Canada.
@en
P2093
A Alperovitch
A Ladogana
H Kretzschmar
I Rietveld
P304
P356
10.1212/01.WNL.0000160117.56690.B2
P407
P577
2005-05-01T00:00:00Z